Fig. 4.
Tumor protection study in mice harboring human PBL xenografts. a, b Human PBL-engrafted mice were injected subcutaneously with SK-Mel-37-NY-ESO157–165 cells and treated intravenously with ImmTAC-NYE (n = 6) or PBS (n = 6) days 1–5. c Tumor volumes plotted against time. Error bars present SEM. ***p < 0.001